[Long-term syndrome in the treatment of parkinsonism with L-dopa and decarboxylase an inhibitor]
{{output}}
In 28% of patients treated for a long time with L-dopa, alone or combined with a decarboxilase inhibitor, the following "long-term syndrome" was observed: decrease in effectiveness, psychic disorders, intense abnormal movements, distonic attitudes, speech and ... ...
